Summary

Global Ambulatory Cardiac Monitoring Devices Market is valued approximately USD 6.21 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 10.53% over the forecast period 2024-2032. Ambulatory cardiac monitoring devices are essential for continuously tracking the heart's electrical activity over time, enabling patients to maintain their daily routines while crucial data is collected. These devices, like Holter monitors (worn for 24-48 hours), event monitors (up to 30 days, triggered by symptoms or abnormalities), mobile cardiac telemetry (real-time monitoring with immediate data transmission), and implantable loop recorders (monitors for up to three years), are vital for diagnosing various heart conditions, especially those with intermittent symptoms. By capturing such events, ensuring patient mobility, and providing accurate diagnoses, these devices facilitate early detection and timely intervention for conditions like atrial fibrillation and bradycardia. They play a pivotal role in modern cardiology, utilizing sensors, electrodes, data storage, transmission, and advanced algorithms for detailed heart monitoring and analysis. The growing adoption of the wearable devices is a key trend supporting the growth of the Global Ambulatory Cardiac Monitoring Devices Market at a substantial rate. The seamless integration of wearable monitors such as smartwatches and patches into daily life appeals to both patients and healthcare practitioners because they allow continuous monitoring in a non-intrusive way.

CVDs are the leading cause of death globally, and their prevalence is on the rise due to factors such as an aging population, increasing obesity rates, and unhealthy lifestyles. Ambulatory cardiac monitoring devices are essential for diagnosing and managing CVDs, which is a major driver of market growth. Also, the growth of the market is attributed to the expanding elderly demographic and heightened research and development investments from major industry players. Growing public awareness about the importance of heart health and favorable reimbursement policies for ambulatory cardiac monitoring procedures are also driving market growth. Moreover, the rise in cardiac ailments like arrhythmia, paired with strong reimbursement frameworks and regulatory guidelines in both developed and emerging markets, is projected to bolster market expansion in the anticipated period. However, the high cost and stringent regulatory environment around ambulatory cardiac monitoring are expected to hinder market expansion over the 2024–2032 projection period.


The key regions considered for the global Ambulatory Cardiac Monitoring Devices Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. In 2023, North America was the largest regional market in terms of revenue. The North America is a dominating region in the Ambulatory Cardiac Monitoring Devices Market, driven by factors such as the escalating prevalence of cardiovascular disease, rapid technological advancements, robust economic growth, and supportive government initiatives. Moreover, the region's growth trajectory is reinforced by a surge in product approvals and launches. For instance, in January 2022, Medilynx cardiac monitoring secured a comprehensive patent in the United States for continuous ECG streaming, analysis, and remote monitoring. Additionally, in May 2021, Vital Connect Inc. introduced its cutting-edge cardiac monitoring patch, the VitalPatch RTM, catering to patients in need of extended Holter monitoring. These developments are expected to further propel market growth in North America throughout the forecast period. Whereas, the market in Asia Pacific is expected to grow at the fastest rate over the forecast period.

Major market player included in this report are:
Koninklijke Philips N.V
Hill-rom Services, Inc.
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
ZOLL Medical Corporation
Nihon Kohden Corporation
Fukuda Denshi Co. Ltd.
iRhythm Technologies Inc
Biotronik SE & Co. KG
General Electric Company
Abbott Laboratories

The detailed segments and sub-segment of the market are explained below:

By Type
ECG Devices
Holter Monitors
Event Monitors
Implantable Loop Recorders
Mobile Cardiac Telemetry

By End-use
Ambulatory Care Centers
Hospitals & Clinics
Others

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Middle East & Africa
Saudi Arabia
South Africa
RoMEA

Years considered for the study are as follows:
Historical year – 2022
Base year – 2023
Forecast period – 2024 to 2032

Key Takeaways:
Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and regional level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market

ページTOPに戻る

Table of Contents

Chapter 1. Global Ambulatory Cardiac Monitoring Devices Market Definition and Research Assumptions
1.1. Research Objective
1.2. Market Definition
1.3. Research Assumptions
1.3.1. Inclusion & Exclusion
1.3.2. Limitations
1.3.3. Supply Side Analysis
1.3.3.1. Availability
1.3.3.2. Infrastructure
1.3.3.3. Regulatory Environment
1.3.3.4. Market Competition
1.3.3.5. Economic Viability (Consumer’s Perspective)
1.3.4. Demand Side Analysis
1.3.4.1. Regulatory frameworks
1.3.4.2. Technological Advancements
1.3.4.3. Environmental Considerations
1.3.4.4. Consumer Awareness & Acceptance
1.4. Estimation Methodology
1.5. Years Considered for the Study
1.6. Currency Conversion Rates

Chapter 2. Executive Summary
2.1. Global Ambulatory Cardiac Monitoring Devices Market Size & Forecast (2022- 2032)
2.2. Regional Summary
2.3. Segmental Summary
2.3.1. By Type
2.3.2. By End-use
2.4. Key Trends
2.5. Recession Impact
2.6. Analyst Recommendation & Conclusion
Chapter 3. Global Ambulatory Cardiac Monitoring Devices Market Dynamics
3.1. Market Drivers
3.2. Market Challenges
3.3. Market Opportunities
Chapter 4. Global Ambulatory Cardiac Monitoring Devices Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.1.7. Porter’s 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Ambulatory Cardiac Monitoring Devices Market Size & Forecasts by Type 2022-2032
5.1. ECG Devices
5.2. Holter Monitors
5.3. Event Monitors
5.4. Implantable Loop Recorders
5.5. Mobile Cardiac Telemetry
Chapter 6. Global Ambulatory Cardiac Monitoring Devices Market Size & Forecasts by End-use 2022-2032
6.1. Ambulatory Care Centers
6.2. Hospitals & Clinics
6.3. Others
Chapter 7. Global Ambulatory Cardiac Monitoring Devices Market Size & Forecasts by Region 2022-2032
7.1. North America Ambulatory Cardiac Monitoring Devices Market
7.1.1. U.S. Ambulatory Cardiac Monitoring Devices Market
7.1.1.1. Type breakdown size & forecasts, 2022-2032
7.1.1.2. End-use breakdown size & forecasts, 2022-2032
7.1.2. Canada Ambulatory Cardiac Monitoring Devices Market
7.2. Europe Ambulatory Cardiac Monitoring Devices Market
7.2.1. U.K. Ambulatory Cardiac Monitoring Devices Market
7.2.2. Germany Ambulatory Cardiac Monitoring Devices Market
7.2.3. France Ambulatory Cardiac Monitoring Devices Market
7.2.4. Spain Ambulatory Cardiac Monitoring Devices Market
7.2.5. Italy Ambulatory Cardiac Monitoring Devices Market
7.2.6. Rest of Europe Ambulatory Cardiac Monitoring Devices Market
7.3. Asia-Pacific Ambulatory Cardiac Monitoring Devices Market
7.3.1. China Ambulatory Cardiac Monitoring Devices Market
7.3.2. India Ambulatory Cardiac Monitoring Devices Market
7.3.3. Japan Ambulatory Cardiac Monitoring Devices Market
7.3.4. Australia Ambulatory Cardiac Monitoring Devices Market
7.3.5. South Korea Ambulatory Cardiac Monitoring Devices Market
7.3.6. Rest of Asia Pacific Ambulatory Cardiac Monitoring Devices Market
7.4. Latin America Ambulatory Cardiac Monitoring Devices Market
7.4.1. Brazil Ambulatory Cardiac Monitoring Devices Market
7.4.2. Mexico Ambulatory Cardiac Monitoring Devices Market
7.4.3. Rest of Latin America Ambulatory Cardiac Monitoring Devices Market
7.5. Middle East & Africa Ambulatory Cardiac Monitoring Devices Market
7.5.1. Saudi Arabia Ambulatory Cardiac Monitoring Devices Market
7.5.2. South Africa Ambulatory Cardiac Monitoring Devices Market
7.5.3. Rest of Middle East & Africa Ambulatory Cardiac Monitoring Devices Market
Chapter 8. Competitive Intelligence
8.1. Key Company SWOT Analysis
8.1.1. Company 1
8.1.2. Company 2
8.1.3. Company 3
8.2. Top Market Strategies
8.3. Company Profiles
8.3.1. Koninklijke Philips N.V
8.3.1.1. Key Information
8.3.1.2. Overview
8.3.1.3. Financial (Subject to Data Availability)
8.3.1.4. Product Summary
8.3.1.5. Market Strategies
8.3.2. Hill-rom Services, Inc.
8.3.3. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
8.3.4. ZOLL Medical Corporation
8.3.5. Nihon Kohden Corporation
8.3.6. Fukuda Denshi Co. Ltd.
8.3.7. iRhythm Technologies Inc
8.3.8. Biotronik SE & Co. KG
8.3.9. General Electric Company
8.3.10. Abbott Laboratories
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes